View ValuationFMC 향후 성장Future 기준 점검 3/6FMC (는) 각각 연간 99.9% 및 4.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 99.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 12.4% 로 예상됩니다.핵심 정보99.9%이익 성장률99.12%EPS 성장률Chemicals 이익 성장20.7%매출 성장률4.8%향후 자기자본이익률12.37%애널리스트 커버리지Good마지막 업데이트11 May 2026최근 향후 성장 업데이트공지 • Feb 05FMC Corporation Provides Earnings Guidance for the First Quarter and Full Year 2026FMC Corporation provides earnings guidance for the first quarter and full year 2026. For the quarter, the company expects revenue excluding India guidance is between $725 million and $775 million, a decline of 5 % at the midpoint versus prior year driven by a mid-single digit price headwind. For the year, the company expects revenue excluding India guidance is $3.60 billion to $3.80 billion, a decline of 5 % at the midpoint versus prior year.공지 • Aug 02FMC Corporation Provides Earnings Guidance for the Third Quarter, Fourth Quarter and Second Half of 2025 and Reaffirms Earnings Guidance for the Full Year 2025FMC Corporation provided earnings guidance for the third quarter, fourth quarter and second half of 2025 and reaffirmed earnings guidance for the full year 2025. For the third quarter, the company expects revenue to be in the range of $1.00 billion to $1.10 billion. For the fourth quarter, the company expects revenue to be in the range of $1.24 billion to $1.34 billion. For the second half, the company expects revenue to be in the range of $2.24 billion to $2.44 billion. For the year, the company expects revenue to be in the range of $4.08 billion to $4.28 billion.모든 업데이트 보기Recent updatesDeclared Dividend • May 02Dividend of US$0.08 announcedShareholders will receive a dividend of US$0.08. Ex-date: 29th June 2026 Payment date: 16th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.Reported Earnings • Apr 30First quarter 2026 earnings released: US$2.09 loss per share (vs US$0.068 loss in 1Q 2025)First quarter 2026 results: US$2.09 loss per share (further deteriorated from US$0.068 loss in 1Q 2025). Revenue: US$758.6m (down 4.1% from 1Q 2025). Net loss: US$261.4m (loss widened US$252.9m from 1Q 2025). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy.공지 • Apr 29FMC Corporation Declares Quarterly Dividend, Payable on July 16, 2026FMC Corporation announced that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on July 16, 2026, to shareholders of record as of the close of business on June 30, 2026.Buy Or Sell Opportunity • Apr 21Now 25% undervaluedThe stock has been flat over the last 90 days, currently trading at €13.54. The fair value is estimated to be €18.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.공지 • Apr 07FMC Corporation Secures Approval for Isoflex Active in the European UnionFMC Corporation announced that Isoflex active, the trade name for bixlozone, has received regulatory approval in the European Union (EU). This approval is a critical milestone in FMC's commercialization process, paving the way for the introduction of formulated products across more than 55 million planted hectares of cereals, corn, oilseed rape and potato in the EU. Product dossiers have been submitted for these crops, and pending regulatory decisions, FMC anticipates launching products powered by Isoflex active beginning in 2027. Isoflex active is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. The molecule provides lasting control of key grass weeds and a wide range of broadleaf weeds, offering growers a new mode of action in cereals, enabling them to effectively manage resistant weed populations and protect economically important crops across the EU. The European launches will build on FMC's global rollout of products powered by Isoflex active, which have already been registered and commercialized in Argentina, Australia, Brazil, Chile, China, Great Britain, Pakistan, Uruguay and India. Products containing Isoflex active have exhibited pre-plant, pre-emergence and early post-emergence selectivity in major crops across the globe, including cereals, cotton, oilseed rape, rice and pulses. Research and development on the use of Isoflex active in additional crops and segments is ongoing.공지 • Mar 25FMC Corporation to Report Q1, 2026 Results on Apr 29, 2026FMC Corporation announced that they will report Q1, 2026 results After-Market on Apr 29, 2026Upcoming Dividend • Mar 23Upcoming dividend of US$0.08 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 16 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of Italian dividend payers (5.0%). Lower than average of industry peers (3.7%).Recent Insider Transactions • Mar 08Insider recently bought €215k worth of stockOn the 4th of March, Michael Barry bought around 18k shares on-market at roughly €11.89 per share. This transaction increased Michael Barry's direct individual holding by 12x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €368k more in shares than they have sold in the last 12 months.공지 • Feb 28+ 1 more updateFMC Corporation Declares Quarterly Dividend, Payable on April 16, 2026FMC Corporation announced that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on April 16, 2026, to shareholders of record as of the close of business on March 31, 2026.공지 • Feb 24FMC Corporation Receives Industry's First Dual Mode of Action Herbicide Classification for RimisoxafenFMC Corporation announced that the Herbicide Resistance Action Committee (HRAC) has classified rimisoxafen as a dual mode of action herbicide, designated under HRAC Groups 12 and 32. This is the first dual mode of action classification in HRAC's history, a significant milestone for the global crop protection industry and validation of FMC's innovative approach to combating herbicide-resistant weeds. The unprecedented classification recognizes rimisoxafen's unique ability to simultaneously inhibit both phytoene desaturase (PDS) and solanesyl diphosphate synthase (SDPS), two critical biochemical pathways in weeds. The dual mode of action makes it far more difficult for weeds to survive and adapt, providing a critical new tool in the fight against herbicide resistance. Herbicide resistance has become an increasingly serious challenge for global agriculture. Palmer amaranth, one of the most economically damaging weed threats facing growers, has developed resistance to eight different herbicide modes of action. Rimisoxafen's dual mode of action creates a significantly higher barrier to resistance development compared to single mode of action herbicides. Rimisoxafen is designed primarily for use in broadacre crops such as corn, soybean, cereals, pulses and sunflower, and will provide effective control of troublesome and resistant broadleaf weeds. Discovered by FMC scientists at the company's Stine Research Center, rimisoxafen represents the third novel herbicide that FMC has developed for regulatory submission in recent years, following Isoflex® active and Dodhylex™ active. FMC expects to begin submitting regulatory dossiers for rimisoxafen in key markets starting in 2026, marking the next step toward bringing this novel technology to growers in key global markets.Reported Earnings • Feb 05Full year 2025 earnings released: US$17.59 loss per share (vs US$3.21 profit in FY 2024)Full year 2025 results: US$17.59 loss per share (down from US$3.21 profit in FY 2024). Revenue: US$3.47b (down 18% from FY 2024). Net loss: US$2.20b (down US$2.60b from profit in FY 2024). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Chemicals industry in Italy.공지 • Feb 05FMC Corporation Provides Earnings Guidance for the First Quarter and Full Year 2026FMC Corporation provides earnings guidance for the first quarter and full year 2026. For the quarter, the company expects revenue excluding India guidance is between $725 million and $775 million, a decline of 5 % at the midpoint versus prior year driven by a mid-single digit price headwind. For the year, the company expects revenue excluding India guidance is $3.60 billion to $3.80 billion, a decline of 5 % at the midpoint versus prior year.공지 • Jan 23FMC Corporation, Annual General Meeting, Apr 28, 2026FMC Corporation, Annual General Meeting, Apr 28, 2026.공지 • Dec 23FMC Corporation to Report Q4, 2025 Results on Feb 04, 2026FMC Corporation announced that they will report Q4, 2025 results After-Market on Feb 04, 2026Declared Dividend • Dec 17Dividend of US$0.08 announcedShareholders will receive a dividend of US$0.08. Ex-date: 30th December 2025 Payment date: 15th January 2026 Dividend yield will be 9.6%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.공지 • Dec 13FMC Corporation Declares Quarterly Dividend, Payable on January 15, 2026FMC Corporation announced that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on January 15, 2026, to shareholders of record as of the close of business on December 31, 2025.공지 • Dec 05FMC Corporation Announces Resignation of Anthony DiSilvestro from Board of Directors, Effective December 3, 2025FMC Corporation announced that on December 3, 2025, Anthony DiSilvestro notified FMC Corporation of his resignation from the Board of Directors and all committees thereof, effective immediately, due to his increased professional commitments following his appointment as Chief Financial Officer of Keurig Dr Pepper Inc. on November 25, 2025, as well as scheduling conflicts with FMC Board and committee meeting dates.Reported Earnings • Oct 30Third quarter 2025 earnings released: US$4.38 loss per share (vs US$0.53 profit in 3Q 2024)Third quarter 2025 results: US$4.38 loss per share (down from US$0.53 profit in 3Q 2024). Revenue: US$542.2m (down 49% from 3Q 2024). Net loss: US$548.9m (down US$614.6m from profit in 3Q 2024). Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.Buy Or Sell Opportunity • Oct 30Now 42% undervalued after recent price dropOver the last 90 days, the stock has fallen 56% to €14.47. The fair value is estimated to be €24.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Meanwhile, the company became loss making.공지 • Oct 30+ 2 more updatesRonaldo Pereira to Step Down as President of FMC Corporation, Effective December 15, 2025FMC Corporation announced that Ronaldo Pereira, president, will be stepping down from his position, effective December 15, 2025. The decision was reached by mutual agreement between Pereira and Pierre Brondeau, chairman and chief executive officer. Pereira will be available in an advisory capacity until December 15, to ensure a smooth transition of responsibilities.공지 • Sep 26FMC Corporation to Report Q3, 2025 Results on Oct 29, 2025FMC Corporation announced that they will report Q3, 2025 results After-Market on Oct 29, 2025Reported Earnings • Aug 04Second quarter 2025 earnings released: EPS: US$0.34 (vs US$2.38 in 2Q 2024)Second quarter 2025 results: EPS: US$0.34 (down from US$2.38 in 2Q 2024). Revenue: US$1.05b (up 1.2% from 2Q 2024). Net income: US$43.1m (down 86% from 2Q 2024). Profit margin: 4.1% (down from 29% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Chemicals industry in Italy.공지 • Aug 02FMC Corporation Provides Earnings Guidance for the Third Quarter, Fourth Quarter and Second Half of 2025 and Reaffirms Earnings Guidance for the Full Year 2025FMC Corporation provided earnings guidance for the third quarter, fourth quarter and second half of 2025 and reaffirmed earnings guidance for the full year 2025. For the third quarter, the company expects revenue to be in the range of $1.00 billion to $1.10 billion. For the fourth quarter, the company expects revenue to be in the range of $1.24 billion to $1.34 billion. For the second half, the company expects revenue to be in the range of $2.24 billion to $2.44 billion. For the year, the company expects revenue to be in the range of $4.08 billion to $4.28 billion.공지 • Aug 01FMC Corporation Obtains Registration in Great Britain for Fundatis®? Herbicide Powered by Isoflex®? ActiveFMC Corporation announced it has received registration for Fundatis®? herbicide powered by Isoflex®? active in Great Britain for use in winter wheat and winter barley. Isoflex®? active is a novel herbicide when used in cereals and is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. Fundatis®? herbicide provides growers with a new tool to help manage herbicide resistance across a wide range of agronomic practices. Fundatis®? herb prevention combines FMC's innovative molecule Isoflex®? active with beflubutamid, providing growers with a new tool for resistance management. Fundatis®? herbicides provides a strong foundation as part of an integrated flower management program, effectively contributing to the control of key annual grass weeds, including Blackgrass (Alopecurus myosuroides) and Italian Ryegrass (Lolium multiflorum). It also offers control of key broadleaf weeds such as Groundsel (Senecio vulgaris) and Speedwell (Veronica spp.). Fundatis®? herbicide will be available to growers during the fall growing season in Great Britain. The registration in Great Britain marks another significant regulatory approval for FMC and Isoflex®? active, which has already been registered and commercialized in Argentina, Australia, Brazil, Chile, China, Pakistan, Uruguay and India. FMC has also submitted a regulatory application for Isoflex®? active In the European Union. Products containing Isoflex®? active have exhibited pre-plant, pre-emergence and early post-emergence selectivity in major crops across the globe, including canola, cereals, oilseed rape and pulses. Research on the use of Isoflex®? activein additional crops and segments is ongoing.공지 • Jul 17FMC Corporation Declares a Quarterly Dividend, Payable on October 16, 2025FMC Corporation announced that its board of directors declared a regular quarterly dividend of 58 cents per share, payable on October 16, 2025, to shareholders of record as of the close of business on September 30, 2025.공지 • Jul 01FMC Corporation Expands Novel Fluindapyr Fungicide Technology to EMEA RegionFMC Corporation announced regulatory approval for Tremisia fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland. Tremisia fungicides combines FMC's proprietary fluindapyr molecule with flutriafol, delivering a dual mode of action to help maintain a healthy crop for an extended period. This fungicide targets a broad spectrum of economically significant diseases, including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The Ukraine registration builds on FMC's successful commercialization of fluindapyr-based products in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval secured in the Philippines earlier this year. Pending regulatory decisions, FMC anticipates launching fluindapyr-based product in Bolivia, Chile, Colombia, Honduras, and India, further expanding global access to this innovative fungicide technology.공지 • Jun 20FMC Corporation to Report Q2, 2025 Results on Jul 30, 2025FMC Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025공지 • Apr 30+ 1 more updateFmc Corporation Declares Quarterly Dividend, Payable on July 17, 2025FMC Corporation announced that its board of directors declared a regular quarterly dividend of 58 cents per share, payable on July 17, 2025, to shareholders of record as of the close of business on June 30, 2025.이익 및 매출 성장 예측BIT:1FMC - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20284,0102852413421112/31/20273,8582651962411612/31/20263,6952275591163/31/20263,435-2,456-220-138N/A12/31/20253,467-2,203-176-80N/A9/30/20253,608-482-407-317N/A6/30/20254,132130-4932N/A3/31/20254,120383198277N/A12/31/20244,246402603671N/A9/30/20244,1681,526496564N/A6/30/20244,0841,465405491N/A3/31/20244,0611,220208313N/A12/31/20234,4871,417-520-386N/A9/30/20234,963593-197-61N/A6/30/20235,358724132269N/A3/31/20235,796817195327N/A12/31/20225,802832447582N/A9/30/20225,594730426540N/A6/30/20225,411762350458N/A3/31/20225,200838407514N/A12/31/20215,045806726820N/A9/30/20214,784621436645N/A6/30/20214,674582467670N/A3/31/20214,588556473673N/A12/31/20204,642579485648N/A9/30/20204,687568534706N/A6/30/20204,617550435620N/A3/31/20204,668547241437N/A12/31/20194,610539N/A489N/A9/30/20194,512663N/A-16N/A6/30/20194,421600N/A-50N/A3/31/20194,370504N/A170N/A12/31/20184,285526N/A368N/A9/30/20184,166124N/A430N/A6/30/20183,888145N/A269N/A3/31/20183,39197N/A292N/A12/31/20172,531-136N/A336N/A9/30/20172,587171N/A429N/A6/30/20172,570150N/A533N/A3/31/20172,529147N/A363N/A12/31/20162,539128N/A498N/A9/30/20162,750-63N/A341N/A6/30/20162,952-109N/A39N/A3/31/20163,224-101N/A40N/A12/31/20152,491-222N/A-358N/A9/30/20153,26551N/A-138N/A6/30/20153,25398N/A87N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 1FMC 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3.3%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: 1FMC (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: 1FMC 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: 1FMC 의 수익(연간 4.8%)이 Italian 시장(연간 5.6%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 1FMC 의 수익(연간 4.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 1FMC의 자본 수익률은 3년 후 12.4%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/11 11:23종가2026/05/11 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스FMC Corporation는 38명의 분석가가 다루고 있습니다. 이 중 16명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Benjamin KalloBairdBenjamin TheurerBarclaysBenjamin TheurerBarclays35명의 분석가 더 보기
공지 • Feb 05FMC Corporation Provides Earnings Guidance for the First Quarter and Full Year 2026FMC Corporation provides earnings guidance for the first quarter and full year 2026. For the quarter, the company expects revenue excluding India guidance is between $725 million and $775 million, a decline of 5 % at the midpoint versus prior year driven by a mid-single digit price headwind. For the year, the company expects revenue excluding India guidance is $3.60 billion to $3.80 billion, a decline of 5 % at the midpoint versus prior year.
공지 • Aug 02FMC Corporation Provides Earnings Guidance for the Third Quarter, Fourth Quarter and Second Half of 2025 and Reaffirms Earnings Guidance for the Full Year 2025FMC Corporation provided earnings guidance for the third quarter, fourth quarter and second half of 2025 and reaffirmed earnings guidance for the full year 2025. For the third quarter, the company expects revenue to be in the range of $1.00 billion to $1.10 billion. For the fourth quarter, the company expects revenue to be in the range of $1.24 billion to $1.34 billion. For the second half, the company expects revenue to be in the range of $2.24 billion to $2.44 billion. For the year, the company expects revenue to be in the range of $4.08 billion to $4.28 billion.
Declared Dividend • May 02Dividend of US$0.08 announcedShareholders will receive a dividend of US$0.08. Ex-date: 29th June 2026 Payment date: 16th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.
Reported Earnings • Apr 30First quarter 2026 earnings released: US$2.09 loss per share (vs US$0.068 loss in 1Q 2025)First quarter 2026 results: US$2.09 loss per share (further deteriorated from US$0.068 loss in 1Q 2025). Revenue: US$758.6m (down 4.1% from 1Q 2025). Net loss: US$261.4m (loss widened US$252.9m from 1Q 2025). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy.
공지 • Apr 29FMC Corporation Declares Quarterly Dividend, Payable on July 16, 2026FMC Corporation announced that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on July 16, 2026, to shareholders of record as of the close of business on June 30, 2026.
Buy Or Sell Opportunity • Apr 21Now 25% undervaluedThe stock has been flat over the last 90 days, currently trading at €13.54. The fair value is estimated to be €18.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
공지 • Apr 07FMC Corporation Secures Approval for Isoflex Active in the European UnionFMC Corporation announced that Isoflex active, the trade name for bixlozone, has received regulatory approval in the European Union (EU). This approval is a critical milestone in FMC's commercialization process, paving the way for the introduction of formulated products across more than 55 million planted hectares of cereals, corn, oilseed rape and potato in the EU. Product dossiers have been submitted for these crops, and pending regulatory decisions, FMC anticipates launching products powered by Isoflex active beginning in 2027. Isoflex active is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. The molecule provides lasting control of key grass weeds and a wide range of broadleaf weeds, offering growers a new mode of action in cereals, enabling them to effectively manage resistant weed populations and protect economically important crops across the EU. The European launches will build on FMC's global rollout of products powered by Isoflex active, which have already been registered and commercialized in Argentina, Australia, Brazil, Chile, China, Great Britain, Pakistan, Uruguay and India. Products containing Isoflex active have exhibited pre-plant, pre-emergence and early post-emergence selectivity in major crops across the globe, including cereals, cotton, oilseed rape, rice and pulses. Research and development on the use of Isoflex active in additional crops and segments is ongoing.
공지 • Mar 25FMC Corporation to Report Q1, 2026 Results on Apr 29, 2026FMC Corporation announced that they will report Q1, 2026 results After-Market on Apr 29, 2026
Upcoming Dividend • Mar 23Upcoming dividend of US$0.08 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 16 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of Italian dividend payers (5.0%). Lower than average of industry peers (3.7%).
Recent Insider Transactions • Mar 08Insider recently bought €215k worth of stockOn the 4th of March, Michael Barry bought around 18k shares on-market at roughly €11.89 per share. This transaction increased Michael Barry's direct individual holding by 12x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €368k more in shares than they have sold in the last 12 months.
공지 • Feb 28+ 1 more updateFMC Corporation Declares Quarterly Dividend, Payable on April 16, 2026FMC Corporation announced that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on April 16, 2026, to shareholders of record as of the close of business on March 31, 2026.
공지 • Feb 24FMC Corporation Receives Industry's First Dual Mode of Action Herbicide Classification for RimisoxafenFMC Corporation announced that the Herbicide Resistance Action Committee (HRAC) has classified rimisoxafen as a dual mode of action herbicide, designated under HRAC Groups 12 and 32. This is the first dual mode of action classification in HRAC's history, a significant milestone for the global crop protection industry and validation of FMC's innovative approach to combating herbicide-resistant weeds. The unprecedented classification recognizes rimisoxafen's unique ability to simultaneously inhibit both phytoene desaturase (PDS) and solanesyl diphosphate synthase (SDPS), two critical biochemical pathways in weeds. The dual mode of action makes it far more difficult for weeds to survive and adapt, providing a critical new tool in the fight against herbicide resistance. Herbicide resistance has become an increasingly serious challenge for global agriculture. Palmer amaranth, one of the most economically damaging weed threats facing growers, has developed resistance to eight different herbicide modes of action. Rimisoxafen's dual mode of action creates a significantly higher barrier to resistance development compared to single mode of action herbicides. Rimisoxafen is designed primarily for use in broadacre crops such as corn, soybean, cereals, pulses and sunflower, and will provide effective control of troublesome and resistant broadleaf weeds. Discovered by FMC scientists at the company's Stine Research Center, rimisoxafen represents the third novel herbicide that FMC has developed for regulatory submission in recent years, following Isoflex® active and Dodhylex™ active. FMC expects to begin submitting regulatory dossiers for rimisoxafen in key markets starting in 2026, marking the next step toward bringing this novel technology to growers in key global markets.
Reported Earnings • Feb 05Full year 2025 earnings released: US$17.59 loss per share (vs US$3.21 profit in FY 2024)Full year 2025 results: US$17.59 loss per share (down from US$3.21 profit in FY 2024). Revenue: US$3.47b (down 18% from FY 2024). Net loss: US$2.20b (down US$2.60b from profit in FY 2024). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Chemicals industry in Italy.
공지 • Feb 05FMC Corporation Provides Earnings Guidance for the First Quarter and Full Year 2026FMC Corporation provides earnings guidance for the first quarter and full year 2026. For the quarter, the company expects revenue excluding India guidance is between $725 million and $775 million, a decline of 5 % at the midpoint versus prior year driven by a mid-single digit price headwind. For the year, the company expects revenue excluding India guidance is $3.60 billion to $3.80 billion, a decline of 5 % at the midpoint versus prior year.
공지 • Jan 23FMC Corporation, Annual General Meeting, Apr 28, 2026FMC Corporation, Annual General Meeting, Apr 28, 2026.
공지 • Dec 23FMC Corporation to Report Q4, 2025 Results on Feb 04, 2026FMC Corporation announced that they will report Q4, 2025 results After-Market on Feb 04, 2026
Declared Dividend • Dec 17Dividend of US$0.08 announcedShareholders will receive a dividend of US$0.08. Ex-date: 30th December 2025 Payment date: 15th January 2026 Dividend yield will be 9.6%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
공지 • Dec 13FMC Corporation Declares Quarterly Dividend, Payable on January 15, 2026FMC Corporation announced that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on January 15, 2026, to shareholders of record as of the close of business on December 31, 2025.
공지 • Dec 05FMC Corporation Announces Resignation of Anthony DiSilvestro from Board of Directors, Effective December 3, 2025FMC Corporation announced that on December 3, 2025, Anthony DiSilvestro notified FMC Corporation of his resignation from the Board of Directors and all committees thereof, effective immediately, due to his increased professional commitments following his appointment as Chief Financial Officer of Keurig Dr Pepper Inc. on November 25, 2025, as well as scheduling conflicts with FMC Board and committee meeting dates.
Reported Earnings • Oct 30Third quarter 2025 earnings released: US$4.38 loss per share (vs US$0.53 profit in 3Q 2024)Third quarter 2025 results: US$4.38 loss per share (down from US$0.53 profit in 3Q 2024). Revenue: US$542.2m (down 49% from 3Q 2024). Net loss: US$548.9m (down US$614.6m from profit in 3Q 2024). Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.
Buy Or Sell Opportunity • Oct 30Now 42% undervalued after recent price dropOver the last 90 days, the stock has fallen 56% to €14.47. The fair value is estimated to be €24.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Meanwhile, the company became loss making.
공지 • Oct 30+ 2 more updatesRonaldo Pereira to Step Down as President of FMC Corporation, Effective December 15, 2025FMC Corporation announced that Ronaldo Pereira, president, will be stepping down from his position, effective December 15, 2025. The decision was reached by mutual agreement between Pereira and Pierre Brondeau, chairman and chief executive officer. Pereira will be available in an advisory capacity until December 15, to ensure a smooth transition of responsibilities.
공지 • Sep 26FMC Corporation to Report Q3, 2025 Results on Oct 29, 2025FMC Corporation announced that they will report Q3, 2025 results After-Market on Oct 29, 2025
Reported Earnings • Aug 04Second quarter 2025 earnings released: EPS: US$0.34 (vs US$2.38 in 2Q 2024)Second quarter 2025 results: EPS: US$0.34 (down from US$2.38 in 2Q 2024). Revenue: US$1.05b (up 1.2% from 2Q 2024). Net income: US$43.1m (down 86% from 2Q 2024). Profit margin: 4.1% (down from 29% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Chemicals industry in Italy.
공지 • Aug 02FMC Corporation Provides Earnings Guidance for the Third Quarter, Fourth Quarter and Second Half of 2025 and Reaffirms Earnings Guidance for the Full Year 2025FMC Corporation provided earnings guidance for the third quarter, fourth quarter and second half of 2025 and reaffirmed earnings guidance for the full year 2025. For the third quarter, the company expects revenue to be in the range of $1.00 billion to $1.10 billion. For the fourth quarter, the company expects revenue to be in the range of $1.24 billion to $1.34 billion. For the second half, the company expects revenue to be in the range of $2.24 billion to $2.44 billion. For the year, the company expects revenue to be in the range of $4.08 billion to $4.28 billion.
공지 • Aug 01FMC Corporation Obtains Registration in Great Britain for Fundatis®? Herbicide Powered by Isoflex®? ActiveFMC Corporation announced it has received registration for Fundatis®? herbicide powered by Isoflex®? active in Great Britain for use in winter wheat and winter barley. Isoflex®? active is a novel herbicide when used in cereals and is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. Fundatis®? herbicide provides growers with a new tool to help manage herbicide resistance across a wide range of agronomic practices. Fundatis®? herb prevention combines FMC's innovative molecule Isoflex®? active with beflubutamid, providing growers with a new tool for resistance management. Fundatis®? herbicides provides a strong foundation as part of an integrated flower management program, effectively contributing to the control of key annual grass weeds, including Blackgrass (Alopecurus myosuroides) and Italian Ryegrass (Lolium multiflorum). It also offers control of key broadleaf weeds such as Groundsel (Senecio vulgaris) and Speedwell (Veronica spp.). Fundatis®? herbicide will be available to growers during the fall growing season in Great Britain. The registration in Great Britain marks another significant regulatory approval for FMC and Isoflex®? active, which has already been registered and commercialized in Argentina, Australia, Brazil, Chile, China, Pakistan, Uruguay and India. FMC has also submitted a regulatory application for Isoflex®? active In the European Union. Products containing Isoflex®? active have exhibited pre-plant, pre-emergence and early post-emergence selectivity in major crops across the globe, including canola, cereals, oilseed rape and pulses. Research on the use of Isoflex®? activein additional crops and segments is ongoing.
공지 • Jul 17FMC Corporation Declares a Quarterly Dividend, Payable on October 16, 2025FMC Corporation announced that its board of directors declared a regular quarterly dividend of 58 cents per share, payable on October 16, 2025, to shareholders of record as of the close of business on September 30, 2025.
공지 • Jul 01FMC Corporation Expands Novel Fluindapyr Fungicide Technology to EMEA RegionFMC Corporation announced regulatory approval for Tremisia fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland. Tremisia fungicides combines FMC's proprietary fluindapyr molecule with flutriafol, delivering a dual mode of action to help maintain a healthy crop for an extended period. This fungicide targets a broad spectrum of economically significant diseases, including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The Ukraine registration builds on FMC's successful commercialization of fluindapyr-based products in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval secured in the Philippines earlier this year. Pending regulatory decisions, FMC anticipates launching fluindapyr-based product in Bolivia, Chile, Colombia, Honduras, and India, further expanding global access to this innovative fungicide technology.
공지 • Jun 20FMC Corporation to Report Q2, 2025 Results on Jul 30, 2025FMC Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025
공지 • Apr 30+ 1 more updateFmc Corporation Declares Quarterly Dividend, Payable on July 17, 2025FMC Corporation announced that its board of directors declared a regular quarterly dividend of 58 cents per share, payable on July 17, 2025, to shareholders of record as of the close of business on June 30, 2025.